And Beckman Coulter.

Today announced that they have entered into an agreement to provide researchers co-developed items from the market leaders in microarrays and automated liquid handlers. The collaboration shall provide researchers with optimized, robust solutions for genomic study, fortified by end-to-end support. This platform provides researchers with standardized systems that consist of all components essential to operate Affymetrix genotyping and gene expression assays.. Affymetrix and Beckman Coulter forge alliance to supply optimized genomic study solutions Affymetrix, Inc.His research has shown that this pathway is commonly activated in malignancy and has paved the way for the development of therapeutics targeted at inhibiting PI3K signaling. This work is having a genuine impact on cancer patients already. He shall present his lecture, ‘Targeting PI3K for Malignancy Therapy,’ Monday, 20 April, 3:30 p.m. ET, in the Grand Ballroom of the Pennsylvania Convention Center. Cantley can be chair of this season's AACR Annual Meeting Scientific Program Committee.